Molecular, Phenotypic Aspects and Therapeutic Horizons of Rare Genetic Bone Disorders
A rare disease afflicts less than 200,000 individuals, according to the National Organization for Rare Diseases (NORD) of the United States. Over 6,000 rare disorders affect approximately 1 in 10 Americans. Rare genetic bone disorders remain the major causes of disability in US patients.
Taha Faruqi +7 more
wiley +1 more source
Myositis ossificans on the forearm in a 10-year-old girl
WOS: 000352078400009PubMed ID: 25647566Myositis ossificans is a rarely encountered benign lesion characterized by a non-neoplastic heterotopic bone formation in both soft tissue and skeletal muscle.
Say, Ferhat +3 more
core +1 more source
Animal models of tendon calcification: Past, present, and future
Various modeling methods for experimental animal models of tendon calcification are shown in the figure: the methods of modeling tendon calcification in experimental animals as shown in the figure can be mainly classified as trauma induced, tissue factor injections, dietary or pharmacological modifications, and gene knockouts.
Ruichen Li +8 more
wiley +1 more source
Monitoring and Management of Fibrodysplasia Ossificans Progressiva: Current Perspectives
Bernard J Smilde,1– 3 Esmée Botman,1– 3 Ruben D de Ruiter,1– 3 Jan Maerten Smit,2,4 Berend P Teunissen,2,5 Wouter D Lubbers,2,6 Lothar A Schwarte,2,6 Patrick Schober,2,6 E Marelise W Eekhoff1– 3 1Amsterdam UMC Location Vrije Universiteit Amsterdam ...
Smilde BJ +8 more
doaj
Fibrodysplasia Ossificans Progressiva: Clinical and Genetic Aspects
Fibrodysplasia ossificans progressiva (FOP) is a severely disabling heritable disorder of connective tissue characterized by congenital malformations of the great toes and progressive heterotopic ossification that forms qualitatively normal bone in ...
Pignolo Robert J +2 more
doaj +1 more source
Progressive Facial Paralysis Caused by Heterotopic Ossification of the Stylohyoid Ligament
OTO Open, Volume 1, Issue 3, July‐September 2017.
Joshua P. Weiss, Peter T. Dziegielewski
wiley +1 more source
Research trends and hotspots of myositis ossificans: a bibliometric analysis from 1993 to 2022
Myositis ossificans (MO) is characterized by benign heterotopic ossificans in soft tissues like muscles, which can be classified into nonhereditary MO and fibrodysplasia ossificans progressiva (FOP). Although MO has been studied for decades, no research
Bowen Lai +3 more
doaj +1 more source
Treatment of myositis ossificans progressiva with a diphosphonate.
The diphosphonate, disodium etidronate (ethane-1-hydroxy-1,1-diphosphonate, 'EHDP'), a compound known to inhibit the crystal growth of hydroxyapatite and to prevent ectopic calcification in experimental animals, has been given to two women with myositis ...
core +1 more source
Myositis Ossificans of the Medial Pterygoid Muscle
Myositis ossificans (MO) is a disease whose main feature is the formation of heterotopic bone involving muscle or any other soft tissue. Pathogenesis is not all clear, but trauma is universally recognized as a trigger event.
Cristiana Bianca +7 more
core +1 more source
An unusual case of rapidly progressive contractures: Case report and brief review
An 8-year-old boy, diagnosed as cervical dystonia, was referred to our tertiary center. After a trivial trauma he had developed painful lumps in the axial region, which was followed by restricted movements of neck, shoulder, and abdominal muscles over 4 ...
Subasree R +3 more
doaj

